» Articles » PMID: 12491013

Percutaneous Transluminal Angioplasty of Dysplastic Stenoses of the Renal Artery: Results on 70 Adults

Overview
Date 2002 Dec 20
PMID 12491013
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Retrospective analysis of the dilatation (PTRA) of renal arterial dysplastic stenosis (RADS).

Methods: Seventy patients suffering from hypertension (87 RADS) were treated at our institution for medial (83%) or non-classified fibrodysplasias (17%). Four patients suffered from renal insufficiency. Two endoprostheses were implanted. We evaluated blood pressure with the USCSRH criteria and renal insufficiency with the Martin criteria.

Results: Ninety-five percent technical success and 87.9% clinical success for blood pressure were obtained, with worse results for patients older than 57 years or with a history of hypertension greater than 9 years. Results were better when the RADS was responsible for an ipsilateral renal atrophy or for poorly controlled hypertension. No renal insufficiency worsened during the follow-up.

Conclusion: PTRA is a first-line treatment for renovascular hypertension caused by RADS. The results were encouraging despite a high average age of the subjects and frequent associated extrarenal vascular lesions.

Citing Articles

Evidence for routine brain-to-pelvis imaging and antiplatelet therapy in patients diagnosed with fibromuscular dysplasia.

Ostergaard M, Hjort N, Buus N, Reinhard M J Clin Hypertens (Greenwich). 2024; 26(8):890-901.

PMID: 39012329 PMC: 11301438. DOI: 10.1111/jch.14865.


Fibromuscular dysplasia in an adult male as a cause of renal artery stenosis and secondary hypertension treated with renal artery stenting.

Bishal K, Malla R, Adhikari C, Rauniyar B, Limbu D Egypt Heart J. 2018; 69(1):81-84.

PMID: 29622959 PMC: 5839349. DOI: 10.1016/j.ehj.2016.09.004.


Clinical characteristics and treatment of renal artery fibromuscular dysplasia with percutaneous transluminal angioplasty: a long-term follow-up study.

Yang Y, Zhang Y, Meng X, Yang K, Jiang X, Wu H Clin Res Cardiol. 2016; 105(11):930-937.

PMID: 27270759 DOI: 10.1007/s00392-016-1001-1.


Optimal management of renal artery fibromuscular dysplasia.

Gottsater A, Lindblad B Ther Clin Risk Manag. 2014; 10:583-95.

PMID: 25114536 PMC: 4122560. DOI: 10.2147/TCRM.S48746.


Current opinions in renovascular hypertension.

Mehta A, Fenves A Proc (Bayl Univ Med Cent). 2010; 23(3):246-9.

PMID: 20671820 PMC: 2900976. DOI: 10.1080/08998280.2010.11928627.